Alterations of the gut mycobiome in patients with MS is a research paper published in EBioMedicine (2021). On theSindex it has a DataRank of 0. It has been cited 74 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: UL1 TR000448
NCATS NIH HHS
Grant: UL1 TR002345
NIDDK NIH HHS
Grant: P30 DK052574
NINDS NIH HHS
Grant: R01 NS102633
FWCI
4.29
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study
Additional file 1 of Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study
Additional file 2 of Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study
Additional file 2 of Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study
Additional file 3 of Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study
Additional file 3 of Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study
Additional file 1 of Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes
Additional file 1 of Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes